drugset / Trial / NCT05106192
Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
Withdrawn
Case Comprehensive Cancer Center
Non-randomizedParallel-groupOpen-labelSupportive care
Summary
A study to compare pain differences between using MedJet needle-free drug-delivery system with standard of care treatment for cutaneous T-cell lymphomas and cutaneous B-cell lymphomas in participants.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2025-06-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bexarotene | Small molecule | 1 % | Topical |
| Background | Triamcinolone Acetonide | Other / unclassified | 10 mg/ml | Other |
| Background | mechlorethamine | Small molecule | 0.016 % | Topical |